[CE contact hours--see below.] : Guests Kathy Byrne, MSN, CRNP, CCRN.,and Lisa Maher, DNP, ARNP, FNP-BC, FPCNA, describe the most common genetic dyslipidemia--elevated lipoprotein (a), or Lp(a). The discussion includes testing for Lp(a)--especially for family members, and others who may be at risk. Resources for patients and HCPs are also part of the conversation.CE LINK:https://pcna.net/online-course/ce-podcast-lpa-closer-to-home-than-you-think PCNA Lp(a) patient education sheet: https://pcna.net/clinical-resources/patient-handouts/lipoproteina-patient-tools-and-handouts/ National Lipid Association: https://www.lipid.org/ Family Heart Foundation: https://familyheart.org/ European Atherosclerosis Society Lp(a) Consensus Statement: https://eas-society.org/page/lipoproteina-consensus-2022/ 2018 AHA/ACC multi-society guidelines: https://www.ahajournals.org/doi/10.1161/CIR.0000000000000625American Heart Association: https://www.heart.org/ See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Only 20% of patients with atrial fibrillation are symptomatic for all their AFib episodes. Guest Dan Sorajja, MD, FACC, FHRS describes AFib diagnosis and patient-based treatment decisions for AFib. Dr. Sorajja also discusses Long QT Syndrome and team-based care.PCNA AFib patient tools: https://pcna.net/clinical-resources/patient-handouts/atrial-fibrillation-tools-and-handouts/PCNA HCP tools (including pocket guide and screening resources): https://pcna.net/clinical-resources/provider-tools/atrial-fibrillation-provider-tools/CE Course: Stroke Prevention Through AFib Recognition & Treatment: https://pcna.net/online-course/start-stroke-prevention-through-afib-recognition-and-treatment/See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Applying guidelines-directed therapies for antiplatelets and antithrombotics requires balancing the risks of cardiovascular events and the risk of bleeding. Guest Erin Michos, MD, MHS, FACC, FAHA, FASE, FASCP, describes the use shared decision-making with patients who are at higher risk for thrombotic events, and discusses pharmacotherapies recommended for use with particular patient groups.2019 AHA/ACC Primary Prevention Guidelines: https://www.ahajournals.org/doi/10.1161/CIR.0000000000000678US Preventive Service Task Force 2022 Aspirin Recommendations: https://www.uspreventiveservicestaskforce.org/uspstf/recommendation/aspirin-to-prevent-cardiovascular-disease-preventive-medicationCURE Trial 2022: https://www.ahajournals.org/doi/10.1161/01.cir.0000029926.71825.e2DAPT risk calculator: https://tools.acc.org/daptriskapp/#!/content/calculator/PRECISE-DAPT score: http://www.precisedaptscore.com/predapt/TWILIGHT trial: https://www.nejm.org/doi/full/10.1056/NEJMoa19084192021 AHA/ACC/SCAI guidelines for acute coronary disease: https://www.ahajournals.org/doi/10.1161/CIR.0000000000001038COMPASS trial: https://www.ahajournals.org/doi/10.1161/CIRCULATIONAHA.120.046048See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

An estimated 8.5 million adults over the age of 40 have PAD, yet up to half have no symptoms. Guest Lola Coke, PhD, ACNS-BC, FAHA, FPCNA, FAAN, describes how the disease disproportionately impacts individuals who are Black, Latinx, and Native American, and how clinician awareness can make a positive difference in effective diagnosis and management.PAD Patient education tools (PCNA): https://pcna.net/clinical-resources/patient-handouts/peripheral-artery-disease-tools-and-handouts/PAD Screening Toolkit, Activity Program: https://pcna.net/clinical-resources/provider-tools/peripheral-artery-disease-provider-tools/See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Hypertrophic Cardiomyopathy (HCM) is the most common genetic heart condition. Typical symptoms, testing, and treatment options are discussed, as well as the role of genetic counseling and referrals to a Center of Excellence in HCM team-based care. Guest: Heidi Salisbury, RN, MSN, CNS-BC, ACGN.Hypertrophic Cardiomyopathy Association: https://4hcm.org/HCM Centers of Excellence: https://4hcm.org/center-of-excellence/PCNA HCM patient education: https://pcna.net/clinical-resources/patient-handouts/hypertrophic-cardiomyopathy-patient-tool/PNCA HCP resources: https://pcna.net/clinical-resources/provider-tools/hypertrophic-cardiomyopathy-provider-tools/PCNA CE Course: HCM in Clinical Practice: https://pcna.net/online-course/hypertrophic-cardiomyopathy-hcm-in-clinical-practice/See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

The assessment and treatment of chest pain--both acute and chronic--is the focus of this conversation with guest Debabrata Mukherjee, MD. Dr. Mukherjee describes risk stratification, appropriate testing, and shared decision-making with patients with chest pain, as well as the importance of preventive care.The HEART score: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6005932/2021 Chest Pain Guidelines: https://www.ahajournals.org/doi/10.1161/CIR.0000000000001029See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Stephanie Little, MSN, RNC-OB, C-EFM, examines cardio-obstetrics, a growing field focused on the link of CVD in patients who are pregnant, post-partum, or have had pregnancy-related health issues. The conversation also includes information about professional development throughout the nursing career, and a review of the importance of nutrition on heart health.PCNA CE Course: https://pcna.net/online-course/reducing-maternal-mortality-through-comprehensive-antenatal-and-postnatal-cardiovascular-care/PCNA online courses: https://pcna.net/professional-development/online-learning/See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

In the final of this three-part content series join colleagues Amy Chybowski, NP and Jonathan Milton, MA, BSN, RN, CCRN-CMC as they discuss the different treatment pathways for patients with pulmonary hypertension (PH). Learn about the three different treatment options and the important role of team-based care.Pulmonary Hypertension Association Patient Resourceshttps://phassociation.org/patients/resources/See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

In this second episode of a three-part content series on pulmonary hypertension (PH) we sit down with Raza Farhan, MD and discuss the diagnosis journey of PH. Dr. Raza describes the nuances behind PH WHO groups and dives into right heart catheterizations.Performance and Interpretation of Invasive Hemodynamic Exercise Testinghttps://www.sciencedirect.com/science/article/abs/pii/S0012369220316172?casa_token=iATn9dmahAoAAAAA:xYsWsL7K7b2TSaYn6ecXbe9fwm1hcdvIDLD7gLEj51KGB98GXgfUyI7GP7NAxD_fgDUJLvdfDistinguishing exercise intolerance in early‐stage pulmonary hypertension with invasive exercise hemodynamics: Rest V E/VCO2 and ETCO2 identify pulmonary vascular diseasehttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC9286332/See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Hear from guests Traci Housten, RN, MS and Lisa Maher, DNP, ARNP, FNP-BC, FPCNA in the first episode of this three-part content series on pulmonary hypertension (PH). Traci and Lisa discuss the complexity around recognizing PH from both the general cardiology and specialty clinician standpoint and dive into what providers should be on the lookout for and which tests can be ordered. They also discuss how family history can play a role, the incidence of pulmonary hypertension, and the impact of a delayed diagnosis.Plumonary Hypertension Associationwww.phassociation.orgGaliè N, Channick RN, Frantz RP, Grünig E, Jing ZC, Moiseeva O, Preston IR, Pulido T, Safdar Z, Tamura Y, McLaughlin VV. Risk stratification and medical therapy of pulmonary arterial hypertension. Eur Respir J. 2019 Jan 24;53(1):1801889. doi: 10.1183/13993003.01889-2018. PMID: 30545971; PMCID: PMC6351343.Hoeper MM, Ghofrani HA, Grünig E, Klose H, Olschewski H, Rosenkranz S. Pulmonary Hypertension. Dtsch Arztebl Int. 2017;114(5):73-84. doi:10.3238/arztebl.2017.0073 Lung Association Pulmonary Hypertension Factshttps://www.lung.org/lung-health-diseases/lung-disease-lookup/pulmonary-arterial-hypertension/learn-about-pulmonary-arterial-hypertension#:~:text=PAH%20is%20most%20common%20in,each%20year%20in%20the%20U.S. See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Hypertension prevention and management is a keystone strategy in reducing CVD risk globally, and guest Eileen Handberg, PhD, ANP-BC, FAHA, FACC, FPCNA, compels nurses to continue to play key leadership roles in this endeavor. Dr. Handberg also shares the importance of involvement in professional associations.PCNA patient ed tools: https://pcna.net/clinical-resources/patient-handouts/hypertension-patient-tools-and-handouts/AHA Blood Pressure Toolkit: https://www.heart.org/en/health-topics/high-blood-pressure/high-blood-pressure-toolkit-resourcesINVEST Trial: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2800790/See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Guest Cindy Lamendola, MSN, NP, FAHA, FPCNA, describes the connections between CVD and diabetes, and related tools for both health care professionals (HCPs) and patients. Cindy also discusses clinical trials, and the role each HCP plays in ensuring representation by diverse populations. Global Heart Hub: https://globalhearthub.org/ Know Diabetes by Heart: https://www.knowdiabetesbyheart.org/Interactive patient education: Diabetes and Your Heart: Close Connections: https://pcna.net/clinical-resources/patient-handouts/diabetes-tools-and-handouts/HCP Tool: Guidelines for Managing Cardiovascular Disease Risk in Patients with Diabetes: https://pcna.net/clinical-resources/provider-tools/diabetes-provider-tools/See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Improving outcomes for patients with CVD requires team-based care and effectively addressing multiple risk factors. Guest Barbara Fletcher, RN, MN, FAHA, FPCNA, FAAN, highlights prevention strategies, and how nurses across the globe can learn from the Cardiovascular Nursing Certificate program. AHA Heart Disease & Stroke Statistics (2023): https://www.ahajournals.org/doi/10.1161/CIR.0000000000001123CV Nursing Certificate: https://pcna.net/professional-development/pcnas-cardiovascular-nursing-certificate/ Global Cardiovascular Nursing Leadership Forum (GCNLF): https://gcnlf.pcna.net/ See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

With 3/4 of adults, 4/5 of elderly individuals and 1/3 of children taking dietary supplements, it is imperative that health care professionals understand what their patients are ingesting and why, and how this may affect other treatments, including for CVD. Guest Rhonda Cooper-DeHoff, PharmD, also addresses cannabinoids, and resources to help you and your patients navigate the sea of dietary supplements. JAMA Patient Pages: https://jamanetwork.com/collections/6258/patient-information ACC CardioSmart Patient & HCP Resources: https://www.cardiosmart.org/ Medlineplus.gov: https://medlineplus.gov/ Herblist app: https://www.nccih.nih.gov/health/herblist-app Dietary Supplement Health & Education Act of 1994: https://ods.od.nih.gov/About/DSHEA_Wording.aspx USP Verification Services: https://www.usp.org/services/verification-services Hemp Farming Act 2018: https://www.congress.gov/bill/115th-congress/senate-bill/2667/textSee Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Guest Carolyn Ho, MD, discusses genetic testing and precision medicine. How can we improve the information we get as part of gathering family history? What role does genetic testing play in in clinical practice--and how can we work collaboratively with our patients and their families to better understand the process and results? Allison Cirino, Role of Genetic Testing in Inherited CVD, JAMA Cardiology: https://jamanetwork.com/journals/jamacardiology/article-abstract/2647085?redirect=true See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Learn about the diagnosis and treatment of resistant hypertension (also called apparent treatment resistant hypertension) from guest Vivek Bhalla, MD. What is the prevalence of this disease? What does the screening process look like, and what does the research support in terms of guideline-directed medical therapy?AHA Scientific Statement on Resistant Hypertension:https://www.ahajournals.org/doi/10.1161/HYP.0000000000000084 Cost Effectiveness Screening PA & Resistant Hypertension, Lubitz, et. al.  https://pubmed.ncbi.nlm.nih.gov/26555126/ Primary Aldosteronism Foundation: https://www.primaryaldosteronism.org/ Stanford Hypertension Center: https://med.stanford.edu/hypertension.html The Endocrine Society: PA Screening https://www.endocrine.org/news-and-advocacy/news-room/featured-science-from-endo-2021/few-patients-at-risk-for-common-high-blood-pressure-disorder-receive-screeningSee Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Hypertension control is an intersection of factors at the patient, provider, system and societal levels. Guest Yvonne Commodore Mensah, PhD, MHS, RN, FAAN, FAHA, FPCNA, describes actions in the clinic, in the community, and in advocacy to help address this disease that affects 1 in 2 U.S. adults. Learn about validated devices for measurement, strategies for effective community screening, and the impacts of health inequity on our patients.Validated blood pressure devices: validatebp.orgHealth Equity and Role of Cardiovascular Nursing: https://pcna.net/health-equity-cardiovascular-nurses-role/Hypertension patient education resources: https://pcna.net/clinical-resources/patient-handouts/hypertension-patient-tools-and-handouts/See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Recognizing the signs of stroke, and helping patients reduce their risk, can significantly improve patient outcomes. Guest Chloe Villavaso, MN, APRN, ACNS-BC, FPCNA, AACC, discusses types of stroke, and how to help our patients reduce their risks.PCNA Stroke Prevention Guide: https://pcna.net/clinical-resources/provider-tools/stroke-prevention-guide/PCNA Legislative Series: Race and Cardiovascular Disease and Stroke in America: https://pcna.net/legislative-series-race-and-cardiovascular-disease-and-stroke-in-america/PCNA Webinar: Stroke Prevention in Patients with Atrial Fibrillation: https://pcna.net/event/webinar-stroke-prevention-in-patients-with-atrial-fibrillation-putting-guidelines-into-practice/American Stroke Association: https://www.stroke.org/See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

In this second of a three-part content series, in partnership with the Medical Alley, we explore the topic of advocacy for patients with obesity. Guests Starlin Haydon-Greatting and Garth Reynolds join Medical Alley's Frank Jaskulke to discuss the barriers to medical coverage for obesity treatment. This episode follows the first podcast, hosted by PCNA, which examined obesity's impacts on cardiovascular disease.Take this short survey to provide feedback on this episode (Thank you in advance): https://forms.gle/111fpVjWhpYEZZVs6See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Join Dr. Erin Ferranti in part one of this three part series in partnership with Medical Alley that explores the bi-directional relationship between obesity and cardiovascular disease. In today's episode, learn about obesity management and how social determinants of health play a role. Take this short survey to provide feedback on this episode (Thank you in advance): https://forms.gle/111fpVjWhpYEZZVs6Register for Series Webinar on March 2: https://pcna.net/event/webinar-obesitys-impact-on-mental-health/The State of Obesity: https://www.tfah.org/wp-content/uploads/2021/09/2021ObesityReport_Fnl.pdfPCNA Obesity Patient Education Material: https://pcna.net/clinical-resources/patient-handouts/obesity-patient-tools/See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Guest Laura Hayman, PhD, RN, FPCNA, FAAN, describes how nurses advocating individually and collectively can impact patients and policies on many levels. As the most trusted healthcare professionals, we have a mandate to advocate for policies designed to improve health, enhance healthcare and healthcare systems, with the overall goal of improving public health.Ernest Grant ANA Advocacy one-pager March 2022: https://www.myamericannurse.com/advocacy-agenda/PCNA Advocacy: https://pcna.net/about/advocacy/advocacy-home/ANA Advocacy: https://www.nursingworld.org/practice-policy/advocacy/See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Guests Erin Poe Ferranti, PhD, MPH, RN, CDCES, FAHA, FPCNA, and Abha Khandelwal MD, MS , FACC, discuss maternal mortality and cardiovascular disease. From the impacts of Social Determinants of Health and health disparities, to the support of the community in supporting women's heart health strategies, learn how positive impacts can be made in any clinical practice setting on women's health.  California Maternal Care Quality Care Collaborative (CMQCC) toolkit: https://www.cmqcc.org/resources-tool-kits/toolkitsSee Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Pamela B. Morris, MD describes women and CVD and the relationship to contraception. Learn the role of cardiovascular professionals in pre-pregnancy counseling, partnering with OB/GYN colleagues to maximize CV health of patients, and the impacts of various contraception types on CV health.U.S. Contraception App (MECUSSPR): https://www.cdc.gov/reproductivehealth/contraception/contraception-app.htmlSee Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

The cardiovascular and cardiometabolic impacts of pregnancy can impact a woman's health throughout her life. It is incumbent on health care professionals caring for women of all ages to seize opportunities to address issues that may have resulted from the 'stress test' of pregnancy. Guest: Emily J. Jones, PhD, RNC-OB, FAHA, FPCNA. Cardiovascular Considerations in Caring for Pregnant Patients: A Scientific Statement From the American Heart Association: https://www.ahajournals.org/doi/full/10.1161/CIR.0000000000000772American Diabetes Association Standards of Medical Care 2022: https://diabetesjournals.org/care/article/46/Supplement_1/S10/148045/1-Improving-Care-and-Promoting-Health-inAmerican College of Obstetricians and Gynecologists: https://www.acog.org/clinical/clinical-guidance/practice-bulletin/articles/2019/05/pregnancy-and-heart-diseaseAmerican College of Obstetricians and Gynecologists: https://www.acog.org/clinical/clinical-guidance/practice-bulletin/articles/2020/06/gestational-hypertension-and-preeclampsiaSee Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

How can diabetes be effectively managed in cardiovascular and primary care practices? Join guests Eryn Bryant, MSN, NP-C, and Sun Kim, MD, MS, as they discuss the challenges and opportunities for helping our patients with diabetes, particularly in using SGLT2 inhibitors and GLP-1 receptor agonists in treatment.JACC expert consensus pathway 2020: https://www.jacc.org/doi/abs/10.1016/j.jacc.2020.05.037American Diabetes Association Standards of Medical Care 2022: https://diabetesjournals.org/care/article/46/Supplement_1/S10/148045/1-Improving-Care-and-Promoting-Health-inSee Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Heart and kidney function are intricately connected, with variations in one impacting the other. Guest Rajesh Mohandas, MD, MPH, discusses chronic kidney disease and the impacts on CVD, chronic kidney disease treatments with cardioprotective effects, and considerations for kidney function when treating CVDs such as heart failure. See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Social media is more than just images of our pets, artfully arranged food, or the latest dance moves. These platforms can be powerful leadership tools for connecting and engaging with colleagues, and showcasing accomplishments. Using social media greatly increases the speed of communication to a wide audience, and can easily reach policymakers about issues that impact nurses and their patients. Guest: Lynne Braun, PhD, CNP, CLS, FAHA, FPCNA, FAAN.See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Kim Cuoma, RN, MSN, CRNP, CHFN, describes the importance of optimal medical therapies and potential barriers for patients, and the role nurses and advanced practice nurses play in increasing compliance with heart failure therapy.See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Hear from Kim Newlin, MSN, ANP, FPCNA, about some of the newest Heart Failure medications and guidelines. She will also discuss conversations with patients that should occur early in their diagnosis, and cardiac rehabilitation programs for these patients.PCNA HF Patient Tools:https://pcna.net/clinical-resources/patient-handouts/heart-failure-tools-and-handout/PCNA HF Tools for HCPs: https://pcna.net/clinical-resources/provider-tools/heart-failure-provider-tools/DAPA-HF Trial: https://www.nejm.org/doi/full/10.1056/NEJMoa1911303EMPEROR-Reduced trial: https://www.nejm.org/doi/full/10.1056/NEJMoa2107038CE course "Heart Failure: Evidenced-based Pharmacologic Therapies"-Kimberly Cuomo, RN, MSN, CRNP, CHFN; part of 2022 Cardiovascular Nursing Symposium: https://pcna.net/online-course/2022-cardiovascular-nursing-symposium-pharmacology-sessions/Million Hearts Cardiac Rehab Change Package: https://millionhearts.hhs.gov/tools-protocols/action-guides/cardiac-change-package/index.htmlSee Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Tune into a conversation between Cindy Bither, ACNP-BC, ANP representing the Preventive Cardiovascular Nurses Association (PCNA) and Ashlee Davis, BSMI, ACS, RDCS, FASE representing the American Society of Echocardiography (ASE) as they discuss the overall importance of echocardiography in diagnosing Cardiac Amyloidosis. Explore the team based perspectives from the speakers as they dive into when to order an echo, what to include in the echo order, and when to use Strain imaging.PCNA Amyloid Podcasts: https://pcna.net/professional-development/heart-to-heart-podcast/PCNA ASE Video: https://pcna.net/clinical-resources/provider-tools/attr-cm-provider-tools/AAHFN Podcast: https://www.aahfn.org/page/PodcastsAAHFN Manual: https://www.aahfn.org/store/viewproduct.aspx?id=16410228ASE Cardiac Amyloidosis Resources: https://www.asecho.org/cardiacamyloidosis/See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

LIsten to a conversation between Janell Grazzini Frantz, CNP, APRN, MSN, and Karen McClean, RN, as they discuss the needs of patietns with ATTR-CM. Explore the patient experience from the time of disease diagnosis, including the need for primary care management. Moderated by Kim Newlin, MSN, ANP, FPCNA.See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Review resources for healthcare professionals and their patients with ATTR-CM, including written/electronic references, websites, mentors, organizations, support groups, clinical trials, and specialty clinics. Episode guests Janell Grazzine Frantz, CNP, APRN, MSN, and Johana Fajardo, DNP, ANP-BC, CHFN, FHFSA, with moderator Kim Newlin, MSN, ANP, FPCNA.Heart Failure Society of America: https://hfsa.org/Amyloidosis Support Groups: https://www.amyloidosissupport.org/International Society of Amyloidosis https://www.isaamyloidosis.org/American Society of Heart Failure Nurses https://www.aahfn.org/A Guide for the Diagnosis and Management of Amyloidosis: https://www.aahfn.org/store/viewproduct.aspx?id=16410228Mayo Clinic - amyloidosis: https://www.mayoclinic.org/diseases-conditions/amyloidosis/diagnosis-treatment/drc-20353183See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Learn about ATTR-CM symptoms and diagnostics, team-based care and specialists, and the importance of the nurse navigator role (even if that isn't your specific job title). Guests Janell Grazzini Frantz, CNP, APRN, MSN, and Linda Wick, MSN, CNP, CHFN, chat with moderator Kim Newlin, MSN, ANP, FPCNA.See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Join Dr. Kathy Wood, PhD, RN, FAHA, FAAN, as she explores utilizing shared decision-making for your AFib patients. Leave this conversation with tools and resources to activate your patient's engagement in their AFib care. Agency for Healthcare Research and Quality (AHRQ) website for Shared Decision Making (the SHARE mnemonic): https://www.ahrq.gov/health-literacy/professional-training/shared-decision/index.html Choosing antithrombotic therapy for elderly patients with atrial fibrillation who are at risk for falls: https://jamanetwork.com/journals/jamainternalmedicine/fullarticle/484991 US hospital webpages on atrial fibrillation ablation: A potential source for misinformation: https://onlinelibrary.wiley.com/doi/abs/10.1111/jce.15606Cardiac tachyarrhythmias and patient values and preferences for their management: the European Heart Rhythm Association (EHRA) consensus document endorsed by the Heart Rhythm Society (HRS), Asia Pacific Heart Rhythm Society (APHRS), and Sociedad Latinoamericana de Estimulación Cardíaca y Electrofisiología (SOLEACE): https://pubmed.ncbi.nlm.nih.gov/26108807/Provider Decision Aid Information:Univ of CO Shared Decision Making website, Colorado Program for Patient Centered Decisions: https://patientdecisionaid.org/  Ottawa Hospital Research Institute: https://decisionaid.ohri.ca/AZlist.html). Dartmouth Center for Shared Decision Making: https://www.dartmouth-hitchcock.org/shared-decision-makingACC’s CardioSmart page on Shared Decision Making: https://www.cardiosmart.org/topics/decisions/shared-decisions Health IT.gov Shared Decision Making tip sheet: https://www.healthit.gov/sites/default/files/nlc_shared_decision_making_fact_sheet.pdf Patient Resources: American Heart Association (AHA) sponsored website “My Afib Experience”: https://supportnetwork.heart.org/s/myafibmain StopAFib.org patient site: https://www.stopafib.org/ Ongoing Trials:ENHANCE AF: https://clinicaltrials.gov/ct2/show/NCT04096781 Univ of Colorado’ Patient Centered Decisions Research Group: https://patientdecisionaid.org/icd/atrial-fibrillation/ See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Atrial Fibrillation (AFib) and Venous Thromboembolism (VTE) have a risky bidirectional relationship. Hear from Carol Patrick, RNFA, ACNP-BC, FPCNA, as she explores this relationship and the different management and prevention techniques. Learn also about how cancer can increase a patient's risk for AFib and VTE. PCNA AFib Resources: https://pcna.net/clinical-resources/provider-tools/atrial-fibrillation-provider-tools/ PCNA VTE Resources: https://pcna.net/clinical-resources/patient-handouts/vte-and-blood-clot-tools-and-handouts/Atherosclerosis Risk in Community (ARIC) Study: https://onlinelibrary.wiley.com/doi/10.1111/jth.13974Pulmonary Embolism and Atrial Fibrillation: Two Sides of the Same Coin? A Systematic Review: https://www.thieme-connect.de/products/ejournals/abstract/10.1055/s-0036-1598005Differential Presentations of Arterial Thromboembolic Events Between Venous Thromboembolism and Atrial Fibrillation Patients: https://www.frontiersin.org/articles/10.3389/fcvm.2021.775564/fullAmerican College of Cardiology, Atrial Fibrillation: Guideline For the Management of Patients: https://www.acc.org/guidelines/hubs/atrial-fibrillationAmerican College of Chest Physicians (CHEST): https://www.chestnet.org/Anticoagulation FORUM, DOAC Playbook: https://acforum-excellence.org/Resource-Center/downloads/DOAC%20Playbook%20_07-2021.pdfNational Blood Clot Alliance: stoptheclot.orgNational Heart, Lung, and Blood Institute (NHLBI): https://www.nih.gov/about-nih/what-we-do/nih-almanac/national-heart-lung-blood-institute-nhlbiWorld Thrombosis Day (WTD): https://www.worldthrombosisday.org/about/wtd/Atrial fibrillation and cancer – An unexplored field in cardiovascular oncology: https://www.sciencedirect.com/science/article/abs/pii/S0268960X18301012?via%3DihubSee Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Atrial Fibrillation (AFib) in conjunction with Heart Failure (HF) can be a fatal combination. Join Dr. Laura VanBrocklin, DNP, FNP, RN-BC, FPCNA, as she explores these co-morbidities and complicated care plans. PCNA AFib Resources: https://pcna.net/clinical-resources/provider-tools/atrial-fibrillation-provider-tools/ PCNA HF Resources: https://pcna.net/clinical-resources/provider-tools/heart-failure-provider-tools/ACC CardioSmart Resources: https://www.cardiosmart.org/topics/atrial-fibrillationHeart Rhythm Society webpage: https://www.hrsonline.org/American Association of Heart Failure Nurses, Heart Failure Prevention Resources: https://www.aahfn.org/page/HFPreventionSee Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Join Nancy Houston Miller, RN, BSN, FAHA, FPCNA, as she discusses the process of health behavior change and resources that can assist you and your patients. Whether the topic is diet, exercise, smoking, medication adherence or other behaviors, partnering with your patients is a key to success.PCNA Behavior Change mini-certificate(CE course): https://pcna.net/online-course/behavior-change-mini-certificate/ Transtheoretical Model of Behavior Change (Prochaska, JO): https://psycnet.apa.org/record/1993-09955-001Social Learning Theory (Bandura): Bandura A. Social Learning Theory. Englewood Cliffs, NJ: Prentice-Hall; 1977.Steve Rollnick: https://www.stephenrollnick.com/William Miller: https://williamrmiller.net/See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

[CE contact hours--see below.] Improving quality of life for patients with heart failure can include lifestyle modifications and require successful behavior change strategies. Learn best practices to apply into your clinical setting from nurse providers Colleen McIlvennan, PhD, DNP, ANP, FAHA, FHFSA, of the University of Colorado in Denver, and Binu Koirala, PhD, MGS, RN, of the Johns Hopkins University School of Nursing in Baltimore.CE LINK: https://pcna.net/?p=10717&post_type=online-course&preview_id=10717PCNA Behavior Change mini-certifice (CE course): https://pcna.net/professional-development/online-learning/ "Behavior Change mini-certificate"AHA HF Tools & Resources: heart.org/en/health-topics/heart-failure/heart-failure-tools-resourcesAdherence to Healthy Sleep Patterns: ahajournals.org/doi/10.1161/CIRCULATIONAHA.120.050792?url_ver=Z39.88-2003&rfr_id=ori%3Arid%3Acrossref.org&rfr_dat=cr_pub++0pubmed&Addressing Social Determinants of Health in Patients with HF: ahajournals.org/doi/10.1161/CIR.0000000000000767See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

[CE contact hours--see below.] Health equity issues, including access ot medications, significantly impact patients with heart failure. From pharmacy deserts to non-medical switching and beyond, hear strategies to assist patients in getting the medications they need, from nurses Binu Koirala, PhD, MGS, RN, with the Johns Hopkins University School of Nursing in Baltimore, and Kim Newlin, MSN, ANP, FPCNA, of Sutter Roseville Medical Center in Northern California. CE LINK: https://pcna.net/?p=10716&post_type=online-course&preview_id=10716 Access to Innovative Medicines Provider Tools: https://pcna.net/clinical-resources/provider-tools/access-for-innovative-medicines-provider-tools/Medicare State Pharmaceutical Assistance Program: medicare.gov/pharmaceutical-assistance-program/#state-programsExtra Help with Medicare Prescription Drug Care Costss: ssa.gov/benefits/medicare/prescriptionhelp.htmlCoverMyMeds: covermymeds.com/main/Solving Medication Access issues: acc.org/latest-in-cardiology/articles/2020/10/01/01/42/feature-advancing-health-equity-for-heart-failure-patientsNon-Medical Switching: cga.ct.gov/2017/rpt/2017-R-0008.htm#:~:text=%E2%80%9CNon%2Dmedical%20switching%E2%80%9D%20broadly,expensive%20but%20therapeutically%20equivalent%20drugHealth Equity: cdc.gov/chronicdisease/healthequity/index.htmUnderstanding Copay Accumulators: https://infusioncenter.org/understanding-copay-accumulators-who-really-benefits/PACH (Partnership to Advance Cardovascular Health): advancecardiohealth.org/See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

[CE contact hours--see below.] Often prescribed for obesity, SGLT2is and GLP-1 RAs have a role in heart failure management. Learn about their mechanisms of action, and how their use extends beyond weight loss to cardioprotective and renalprotective properties. Guests: Kim Newlin, MSN, ANP, FPCNA, of Sutter Roseville Medical Center in Northern California, and Colleen McIlvennan, PhD, DNP, ANP, FAHA, FHFSA, from the University of Colorado in Denver.  CE Link: https://pcna.net/?p=10718&post_type=online-course&preview_id=10718 2022 AHA/ACC/HFSA 2022 Guideline for the Managment of HF: https://www.ahajournals.org/doi/10.1161/CIR.0000000000001063Pocket Guide: Guidelines for Managing CVD Risk in Patients with Diabetes: https://pcna.net/clinical-resources/provider-tools/diabetes-provider-tools/HF Pocket Guide: A Guide to Prevention and Management: https://pcna.net/clinical-resources/provider-tools/heart-failure-provider-tools/ New and Emerging Treatments for Heart Failure: HFrEF and HFpEF (CE course): https://pcna.net/online-course/new-and-emerging-treatments-for-heart-failure-hfref-and-hfpef/ SGLT2is in Heart Failure: ncbi.nlm.nih.gov/pmc/articles/PMC8654149/SGLT2i in HFpEF: multicenter randomized trial: nature.com/articles/s41591-021-01536-xEmpagliflozin in HFpEF: https://www.nejm.org/doi/10.1056/NEJMoa2107038#:~:text=Empagliflozin%20in%20HF%20with%20Preserved%20Ejection%20Fraction&text=Sodium%E2%80%93glucose%20cotransporter%202%20(SGLT2,and%20a%20reduced%20ejection%20fraction. See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Atrial fibrillation (AFib) management includes both pharmacologic and non-pharmacologic therapies.Guest Bill Miles, MD, FACC, of the University of Florida, Gainsville, describes how to effectively treat AFib--from asymptomatic younger patients without left ventricular dysfunction to older patients with significantly reduced ejection fraction.AFib resources for patientsAFib resources for healthcare providersSee Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

The interrelationship of sleep apnea and atrial fibrillation (AFib) should be front of mind for clinicians. Learn keys to guideline-directed therapy including diagnosis, risk scores, the importance of anticoagulation, rate- and rhythm-controlling medications, and pacemakers, from guest Lisa Maher, DNP, ARNP, FNP-BC, FPCNA, Unitypoint Health Allen Hospital Cardiovascular Center.AFib resources for patientsAFib resources for healthcare providersSee Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Sexual and gender minorities--those identified as LGBQT+--are at increased risk of cardiovascular disease. Investigate the connections between heart health and minority stressors, poverty, care delays or avoidance, discrimination, and other factors affecting our patients, and how nurses can positively impact care and outcomes. Guest: Billy Cacaeres, PhD, RN, AGPCNC-BC, FAAN, of Columbia University.Gay and Lesbian Medical Association glma.orgNational LGBTQIA+ Education Center lgbtqiahealtheducation.orgSee Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Cardiovascular disease prevention can--and should--begin before patients develop any risk factors. Learn about strategies for primoridial prevention (including maternal risks of CVD), reducing health disparities, and how they can be applied in clinical practice--no matter where patients are in their lifespan. Guest: Don Lloyd-Jones, President of the American Heart Association, and Chair of the Dept. of Preventive Medicine at Northwestern University.See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Familial Hypercholesterol, the genetic condition that causes high LDL cholesterol levels, may lead to early heart attacks or heart disease If undiagnosed or untreated. Guest Susan Halli Demeter, DNP, CNP, NP, of the Mayo Clinic, describes diagnosis, heterozyogus and homozygous versions, treatments, and the importance of genetic screening for family members.CE course The Role of Non-Statin Therapies in Optimal Cholesterol ManagementPatient education What is Familial Hypercholesterolemia?Patient & professional tools: Access to Innovative MedicinesSee Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Developing and demonstrating leadership--regardless of your job title--helps improve patient outcomes, job satisfaction, and career advancement. Learn about the Future of Nursing repot, and how mentorship, training, and resources can help you in your career journey. Guest: Sandra B. Dunbar, RN, PhD, FAAN, FAHA, FPCNA, of Emory University.Advancing the Cardiovascular Nursing Profession: https://pcna.net/advancing-the-cardiovascular-nursing-profession/ PCNA Leadership Series: https://pcna.net/event/leadership-series-leadership-in-the-workplace/ See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Cardio-oncology requires a team of individuals--primary care, oncology, cardiology, families, and caregivers--supporting the patient and the shared decision-making process. The COVID-19 pandemic effects on cardio-oncology are discussed, along with informational resources. Guests: Janet Celli, BSN, RN, PCCN, and Kerry Skurka, RN, BSN, F-ICOS. Resources:American College of Cardiology CardioSmart: cardiosmart.orgICOS: ic-os.orgCancer Support Community: cancersupportcommunity.orgAssociation of Community Cancer Centers: accc-cancer.orgLittle Red Door: littlereddoor.orgSee Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Patients with cancer are at increased risk of cardiovascular disease, months or years following their final cancer treatment--and the comorbidities for cancer and CVD overlap significantly. Guests Janet Celli, BSN, RN, PCCN, and Kerry Skurka, RN, BSN, F-ICOS, discuss risk reduction and the impact of health equity in these patients.Resources:American College of Cardiology CardioSmart: cardiosmart.orgICOS: ic-os.orgCancer Support Community: cancersupportcommunity.orgAssociation of Community Cancer Centers: accc-cancer.orgK Red Door: littlereddoor.orgSee Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.